Omid Hamid Selected Research

Omid Hamid Research Topics

Disease

117	Melanoma (Melanoma, Malignant) 04/2024 - 01/2007
76	Neoplasms (Cancer) 02/2024 - 12/2007
16	Disease Progression 12/2021 - 06/2012
14	Neoplasm Metastasis (Metastasis) 01/2024 - 05/2012
10	Brain Neoplasms (Brain Tumor) 01/2024 - 05/2012
9	Fatigue 01/2021 - 05/2012
8	Colitis 12/2021 - 01/2007
7	Uveal melanoma 12/2023 - 01/2020
7	Exanthema (Rash) 12/2023 - 05/2012
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 06/2013
6	Fever (Fevers) 12/2023 - 11/2012
5	Merkel Cell Carcinoma 01/2022 - 10/2016
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 07/2012
5	Body Weight (Weight, Body) 08/2018 - 07/2013
4	COVID-19 04/2024 - 01/2020
4	Pruritus (Itching) 12/2023 - 05/2015
4	Diarrhea 01/2021 - 09/2009
4	Nausea 01/2021 - 06/2012
3	Neutropenia 08/2015 - 03/2014
2	Breast Neoplasms (Breast Cancer) 02/2024 - 01/2019
2	Lymphoma (Lymphomas) 01/2023 - 01/2017
2	Squamous Cell Carcinoma of Head and Neck 10/2022 - 01/2019
2	Hypophysitis 12/2021 - 01/2017
2	Neurologic Manifestations (Neurological Manifestations) 11/2021 - 08/2018
2	Vomiting 01/2021 - 06/2012
2	Pneumonia (Pneumonitis) 01/2021 - 08/2015
2	Lymphatic Metastasis 01/2019 - 05/2015
2	Basal Cell Carcinoma (Rodent Ulcer) 01/2019 - 01/2017
2	Chills 10/2018 - 06/2012
2	Myalgia 08/2015 - 08/2014
1	Hypotension (Low Blood Pressure) 12/2023
1	Bites and Stings (Sting) 01/2023

Drug/Important Bio-Agent (IBA)

49	IpilimumabIBA 12/2023 - 12/2007
32	pembrolizumabIBA 01/2024 - 07/2013
25	Immune Checkpoint InhibitorsIBA 10/2023 - 07/2013
19	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2024 - 11/2012
13	Monoclonal AntibodiesIBA 01/2021 - 11/2011
11	dabrafenibIBA 01/2022 - 05/2012
10	Biomarkers (Surrogate Marker)IBA 04/2024 - 11/2011
10	trametinibIBA 01/2022 - 11/2012
9	B7-H1 AntigenIBA 10/2023 - 06/2013
8	VemurafenibIBA 01/2020 - 05/2012
7	NivolumabIBA 04/2024 - 04/2017
7	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2023 - 03/2016
6	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2023 - 12/2007
6	talimogene laherparepvecIBA 01/2023 - 01/2016
6	AntigensIBA 10/2021 - 12/2007
6	atezolizumabIBA 01/2020 - 11/2014
5	tebentafuspIBA 12/2023 - 11/2020
5	VaccinesIBA 10/2023 - 05/2014
5	AntibodiesIBA 10/2023 - 09/2011
5	Proteins (Proteins, Gene)FDA Link 01/2023 - 03/2012
5	CTLA-4 AntigenIBA 01/2023 - 01/2014
5	CytokinesIBA 01/2021 - 01/2013
5	LigandsIBA 10/2019 - 06/2012
4	Glycoproteins (Glycoprotein)IBA 12/2023 - 11/2014
4	Dacarbazine (DIC)FDA LinkGeneric 12/2023 - 01/2013
4	avelumabIBA 01/2020 - 10/2016
4	cobimetinibIBA 01/2020 - 08/2014
3	Interleukin-2 (IL2)IBA 02/2024 - 07/2013
3	HLA-A Antigens (HLA-A)IBA 12/2023 - 01/2021
3	Programmed Cell Death 1 ReceptorIBA 10/2023 - 01/2019
3	tremelimumabIBA 01/2023 - 12/2007
3	durvalumabIBA 01/2023 - 10/2016
3	Alanine Transaminase (SGPT)IBA 12/2021 - 01/2017
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021 - 05/2012
3	Immunoconjugates (Immunoconjugate)IBA 01/2020 - 11/2014
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2020 - 01/2007
3	epacadostatIBA 01/2019 - 11/2018
3	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2019 - 11/2011
3	EnzymesIBA 11/2018 - 08/2014
3	Paclitaxel (Taxol)FDA LinkGeneric 07/2014 - 01/2013
2	Sunitinib (Sutent)FDA Link 02/2024 - 03/2012
2	Bevacizumab (Avastin)FDA Link 04/2019 - 02/2015
2	glembatumumab vedotinIBA 01/2019 - 11/2014
2	HhAntag691IBA 01/2019 - 01/2017
2	Codon (Codons)IBA 01/2019 - 12/2017
2	SteroidsIBA 10/2017 - 09/2009
2	Cytotoxins (Cytolysins)IBA 11/2014 - 12/2009
2	Peptides (Polypeptides)IBA 05/2014 - 01/2007
2	Carboplatin (JM8)FDA LinkGeneric 01/2013 - 01/2013
2	Budesonide (Pulmicort)FDA LinkGeneric 01/2012 - 09/2009
1	Vancomycin FDA LinkGeneric 04/2024
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2024
1	binimetinibIBA 01/2024
1	encorafenibIBA 01/2024
1	spartalizumabIBA 01/2023
1	Immunoglobulin G (IgG)IBA 01/2023
1	Indicators and Reagents (Reagents)IBA 11/2022

Therapy/Procedure

61	Therapeutics 01/2024 - 12/2007
23	Immunotherapy 10/2023 - 12/2007
11	Drug Therapy (Chemotherapy) 10/2023 - 01/2013
5	Cell- and Tissue-Based Therapy (Cell Therapy) 02/2024 - 05/2014
3	Intravenous Infusions 01/2019 - 01/2017
2	Injections 10/2023 - 10/2018
2	Aftercare (After-Treatment) 01/2023 - 05/2012
2	Lymph Node Excision (Lymph Node Dissection) 11/2021 - 01/2018
2	Neoadjuvant Therapy 10/2019 - 01/2019
2	Radiotherapy 04/2019 - 01/2014
1	Oncolytic Virotherapy 10/2023